Annemarie Hanekamp has overseen some of the most transformative changes in oncology over her years in Big Pharma. Now, she ...
At the healthcare conference, Moderna lowered expected 2025 revenue to the range of $1.5 billion to $2.5 billion -- down from ...
Moderna (NASDAQ: MRNA) shareholders have been having a rough time lately. The biotech stock rocketed higher last spring, but ...
We recently published a list of 11 Stocks That Will Go to the Moon According to Reddit. In this article, we are going to take ...
22hon MSN
Short interest for healthcare stocks in S&P 500 rose slightly in December vs. November, while Moderna continued to be the most shorted stock of the month. The average short interest for S&P 500 Health ...
The firm noted Moderna's reduced 2024 sales forecast of $3.0–$3.1 billion, down from $3.0–$3.5 billion, driven by declines in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback